STAAR Surgical Company
NASDAQ:STAAMedical - Instruments & Supplies
-$0.40 today
- Market cap
- $1.27B
- Beta
- 1.23
- P/E (TTM)
- -68.3
- EPS (TTM)
- -$0.42
Volume 0.45M
Average 1.07M
STAA Net Income
Bottom-line profit after all expenses, interest, and taxes.
STAAR Surgical CompanyNASDAQ: STAA
Net Income · Q1 FY2026 · quarter ended Apr 2026
Net income turns positive
Q1 FY2026 net income was $5.21M, compared with -$54.21M a year earlier. Trailing-twelve-month net income was -$21.03M.
Context
- Net income amounted to 33.6% of revenue in FY2025, up 27.2 pp from a year earlier.
- Net income increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 7 analysts of $17.04M (+121.2%) for the fiscal year ending Jan 2027, a step up from the -298.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $5.21M+128.4% QoQ
- Last fiscal yearJan 2026
- -$80.45M-298.1% YoY
- LTMApr 2026
- -$21.03M+70.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +109.6% | +167.7% | +58.1 pp |
| 1 year | -298.1% | +121.2% | +419.3 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- (80.45M) USD
- Year-over-year change
- -298.1%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-02 | (80.45M) | -298.1% |
| FY2024 | 2024-12-27 | (20.21M) | -194.7% |
| FY2023 | 2023-12-29 | 21.35M | -46.2% |
| FY2022 | 2022-12-30 | 39.67M | +44.2% |
| FY2021 | 2021-12-31 | 27.51M | — |
Net Income vs competitors
How STAA compares with its peers on the latest reported figures
- STAA's LTM Apr 2026 net income of -$21.03M is the 3rd highest of the 5 companies compared; the peer median is $261.83M.
- Its year-over-year change of +70.4% is the highest of 5, against a peer median of +0.3%.
- Net income amounts to 7.2% of revenue for STAA, versus a peer median of 9.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $662.33M | -36.7% | +43.0% | 6.1% | |
| LTM Jul 2026 | $570.3M | +39.8% | -1.0% | 13.5% | |
| LTM Apr 2026 | -$21.03M | +70.4% | — | 7.2% | |
| LTM Mar 2026 | -$46.64M | -75.7% | — | 36.6% | |
| LTM Jun 2026 | -$171M | +37.4% | — | 3.2% | |
| Peer median (excluding STAA) | $261.83M | +0.3% | +21.0% | 9.8% | |
Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 230.47M | 284.39M | 322.42M | 313.9M | 239.44M |
| Cost of Revenue | 51.84M | 61.01M | 69.76M | 74.32M | 57.02M |
| Gross Profit | 178.64M | 223.38M | 252.65M | 239.58M | 182.42M |
| Gross Margin | 77.5% | 78.5% | 78.4% | 76.3% | 76.2% |
| Research & Development | 33.86M | 35.98M | 44.4M | 53.97M | 40.06M |
| Selling, General & Admin | 111.44M | 143.6M | 180.15M | 198.22M | 188.31M |
| Operating Expenses | 145.3M | 179.58M | 224.55M | 252.19M | 228.37M |
| Depreciation & Amortization | 3.64M | 4.51M | 5.12M | 6.89M | 8.73M |
| EBITDA | 34.98M | 50.06M | 38.82M | (2.16M) | (73.54M) |
| EBITDA Margin | 15.2% | 17.6% | 12.0% | -0.7% | -30.7% |
| Operating Income | 33.34M | 43.8M | 28.1M | (12.61M) | (45.95M) |
| Operating Margin | 14.5% | 15.4% | 8.7% | -4.0% | -19.2% |
| Interest Income | — | 2.45M | 6.99M | 5.91M | 4.59M |
| Interest Expense | 38K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (2.04M) | 1.75M | 5.6M | 3.56M | (36.32M) |
| Income Before Tax | 31.3M | 45.55M | 33.7M | (9.05M) | (82.26M) |
| Pre-Tax Margin | 13.6% | 16.0% | 10.5% | -2.9% | -34.4% |
| Income Tax Expense | 3.79M | 5.89M | 12.35M | 11.16M | (1.82M) |
| Net Income | 27.51M | 39.67M | 21.35M | (20.21M) | (80.45M) |
| Net Margin | 11.9% | 13.9% | 6.6% | -6.4% | -33.6% |
| EPS (Basic) | 0.52 | 0.83 | 0.44 | (0.41) | (1.62) |
| EPS (Diluted) | 0.50 | 0.80 | 0.43 | (0.41) | (1.62) |
| Weighted Avg Shares | 47.21M | 47.99M | 48.52M | 49.13M | 49.57M |
| Weighted Avg Shares (Diluted) | 49.46M | 49.38M | 49.43M | 49.13M | 49.57M |
STAAR Surgical Company
NASDAQ:STAA
Intrinsic Alpha fair value
Locked
Current Price
$25.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.